•Itching
•Skin rash (including photosensitivity)
•Fatigue
•Fever
•Weakness
Less frequent: may affect up to 1 in 100 people
•Lack of sleep
•Hives
•Diffuse hair loss (its relationship with treatment is unclear)
Rare: may affect up to 1 in 1,000 people
•Severe allergic reaction (anaphylaxis)
•Difficulty breathing (dyspnea)
•Reversible increases in bilirubin and liver enzymes
•Angioedema
•Increased blood urea and creatinine
Very rare: affects up to 1 in 10,000 people
•Changes in blood count (anemia, leukopenia, thrombocytopenia)
•Sensation of detachment (reversible after treatment interruption), agitation, psychotic symptomsShaking, ataxia, dysarthria, seizures, encephalopathy, alterations in consciousness up to coma
The previously mentioned reversible side effects generally occurred in patients with renal function disorders or with other predisposing factors, but cannot be attributed entirely to these characteristics.
•Hepatitis, jaundice
•Acute renal failure, renal pain
Reporting of side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https:/www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging, after "Do not use after" or "CAD".
Do not store at a temperature above 25°C.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
What Aciclovir Stada looks like and contents of the pack
Aciclovir Stada 200 mg tablets are white, round, and flat tablets.
Each pack of Aciclovir Stada 200 mg tablets contains 25, 50, 100, or 500 tablets or 25x1 tablets (unit dose) in blisters with 5 tablets.
Only some pack sizes may be marketed.
Marketing authorization holder and responsible for manufacturing
Marketing authorization holder
STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Responsible for manufacturing
STADA Arzneimittel AG,
Stadastrasse 2- 18
61118 Bad Vilbel (Germany)
or
LAMP San Prospero S.p.A
Via della Pace 25/A
41030 SanProspero, Modena
(Italy)
or
Centrafarm Services, B.V
4814 NE Breda
(Netherlands)
or
Sanico NV
Veedijk 59
2300 Turnhout
Belgium
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Belgium:Aciclovir EG 200 mg tablets
Denmark:Aciclodan 200 mg
Spain:Aciclovir Stada 200 mg tablets EFG
Finland:Acyclostad 200 mg tablets
Netherlands:Aciclovir CF 200 mg, tablets
Portugal:Aciclovir Ciclum 200 mg tablets
Sweden:Aciklovir STADA 200 mg
Last review date of this leaflet:August 2023
The detailed information of this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.